A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the long-used medicine could be repurposed to combat MS in people with female ...

16:40 EDT Classover (KIDZ) files to sell 534,740 shares of Class B common stock for holders Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...

16:00 EDT OBOOK Holdings (OWLS) Inc. Class A Common Shares trading resumes Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Nearly 5% of people — including social media influencer Kim Kardashian — have or will develop a brain aneurysm over the course of their lifetimes, according to Thomas Jefferson University Hospital.

Parkinson’s disease — which can cause tremors, slow movement and stiffness — is believed to affect 1 in every 336 Americans. The exact cause of the neurodegenerative disorder is not known, but it is ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Fans tuning into "The Kardashians" got a shocking health update on Thursday, Oct. 23, as Kim Kardashian revealed she was diagnosed with a small brain aneurysm. Kim Kardashian was diagnosed of a small ...

Email notifications are only sent once a day, and only if there are new matching items. For Sakura Tafoya, it started with a header. The Santa Fe girl and her family were playing soccer on a fall day ...

How is it that we all see the world in a similar way? Imagine sitting with a friend in a café, both of you looking at a phone screen displaying a dog running along the beach. Although each of our ...

MALVERN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for ...